ArticleJournal of clinical medicine research2017

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus.

Takehiro Kawata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.